| Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice C Lasagna-Reeves, D Gonzalez-Romero, MA Barria, I Olmedo, A Clos, ... Biochemical and biophysical research communications 393 (4), 649-655, 2010 | 723 | 2010 |
| Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice CA Lasagna-Reeves, DL Castillo-Carranza, U Sengupta, AL Clos, ... Molecular neurodegeneration 6, 1-14, 2011 | 624 | 2011 |
| Identification of oligomers at early stages of tau aggregation in Alzheimer's disease CA Lasagna-Reeves, DL Castillo-Carranza, U Sengupta, J Sarmiento, ... The FASEB Journal 26 (5), 1946, 2012 | 558 | 2012 |
| Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau CA Lasagna-Reeves, DL Castillo-Carranza, U Sengupta, ... Scientific reports 2 (1), 700, 2012 | 550 | 2012 |
| Molecular mechanisms of amyloid oligomers toxicity R Kayed, CA Lasagna-Reeves Journal of Alzheimer's Disease 33 (s1), S67-S78, 2013 | 547 | 2013 |
| Preparation and characterization of neurotoxic tau oligomers CA Lasagna-Reeves, DL Castillo-Carranza, MJ Guerrero-Muñoz, ... Biochemistry 49 (47), 10039-10041, 2010 | 375 | 2010 |
| Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles DL Castillo-Carranza, U Sengupta, MJ Guerrero-Muñoz, ... Journal of Neuroscience 34 (12), 4260-4272, 2014 | 303 | 2014 |
| TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy SM Bemiller, TJ McCray, K Allan, SV Formica, G Xu, G Wilson, ... Molecular neurodegeneration 12, 1-12, 2017 | 241 | 2017 |
| Specific targeting of tau oligomers in htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds DL Castillo-Carranza, JE Gerson, U Sengupta, MJ Guerrero-Muñoz, ... Journal of Alzheimer's Disease 40 (s1), S97-S111, 2014 | 189 | 2014 |
| Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies U Sengupta, MJ Guerrero-Muñoz, DL Castillo-Carranza, ... Biological psychiatry 78 (10), 672-683, 2015 | 181 | 2015 |
| Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain CA Lasagna-Reeves, CG Glabe, R Kayed Journal of Biological Chemistry 286 (25), 22122, 2011 | 174 | 2011 |
| Reduction of Nuak1 decreases tau and reverses phenotypes in a tauopathy mouse model CA Lasagna-Reeves, M de Haro, S Hao, J Park, MWC Rousseaux, ... Neuron 92 (2), 407-418, 2016 | 145 | 2016 |
| TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau MWC Rousseaux, M de Haro, CA Lasagna-Reeves, A De Maio, J Park, ... elife 5, e19809, 2016 | 108 | 2016 |
| Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity CA Lasagna-Reeves, AL Clos, D Castillo-Carranza, U Sengupta, ... Biochemical and biophysical research communications 430 (3), 963-968, 2013 | 100 | 2013 |
| Characterization of tau oligomeric seeds in progressive supranuclear palsy JE Gerson, U Sengupta, CA Lasagna-Reeves, MJ Guerrero-Muñoz, ... Acta neuropathologica communications 2, 1-9, 2014 | 99 | 2014 |
| The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes CA Lasagna-Reeves, U Sengupta, D Castillo-Carranza, JE Gerson, ... Acta neuropathologica communications 2, 1-13, 2014 | 83 | 2014 |
| Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies C A Lasagna-Reeves, D L Castillo-Carranza, G R Jackson, R Kayed Current Alzheimer Research 8 (6), 659-665, 2011 | 81 | 2011 |
| Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease MJ Guerrero-Muñoz, DL Castillo-Carranza, S Krishnamurthy, ... Neurobiology of disease 71, 14-23, 2014 | 70 | 2014 |
| Inhaled insulin forms toxic pulmonary amyloid aggregates CA Lasagna-Reeves, AL Clos, T Midoro-Hiriuti, RM Goldblum, ... Endocrinology 151 (10), 4717, 2010 | 56 | 2010 |
| The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer’s disease M Moutinho, SS Puntambekar, AP Tsai, I Coronel, PB Lin, BT Casali, ... Science translational medicine 14 (637), eabl7634, 2022 | 48 | 2022 |
Rakez Kayedutmb在 utmb.edu 的电子邮件经过验证
